Effects of APOE rs429358, rs7412 and GSTM1/GSTT1 polymorphism on plasma and erythrocyte antioxidant parameters and cognition in old Chinese adults

Nutrients

Volumn 7, Issue 10, 2015, Pages 8261-8273

  Yuan, Linhong ^a   Liu, Jinmeng ^a   Dong, Li ^a   Cai, Can ^a   Wang, Sisi ^a   Wang, Bo ^a   Xiao, Rong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Antioxidant biomarkers; Cognition; Polymorphism; The elderly

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN E; CATALASE; CHOLESTEROL; FOLIC ACID; GLUCOSE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; RETINOL; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; ANTIOXIDANT; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ALLELE; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMICAL ANALYSIS; BODY MASS; CHRONIC DISEASE; COGNITION; CROSS-SECTIONAL STUDY; DNA ISOLATION; DNA POLYMORPHISM; EDUCATION; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MONTREAL COGNITIVE ASSESSMENT; PLASMA; POLYMERASE CHAIN REACTION; QUESTIONNAIRE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SMOKING; VITAMIN BLOOD LEVEL; AGING; BLOOD; CHEMISTRY; CHINA; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED;

AGED; AGING; ALPHA-TOCOPHEROL; ANTIOXIDANTS; APOLIPOPROTEINS E; CATALASE; CHINA; CHOLESTEROL, LDL; COGNITION; CROSS-SECTIONAL STUDIES; ERYTHROCYTES; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; TRIGLYCERIDES;

EID: 84942761950     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7105391     Document Type: Article

References (47)

1. Jorm, A.F.; Jolley, D. The incidence of dementia: A meta-analysis. Neurology 1998, 51, 728–733. [CrossRef] [PubMed]
2. Sultana, R.; Piroddi, M.; Galli, F.; Butterfield, D.A. Protein levels and activity of some antioxidant enzymes in hippocampus of subjects with amnestic mild cognitive impairment. Neurochem. Res. 2008, 33, 2540–2546. [CrossRef] [PubMed]
3. Solfrizzi, V.; D’Introno, A.; Colacicco, A.M.; Capurso, C.; Todarello, O.; Pellicani, V.; Capurso, S.A.; Pietrarossa, G.; Santamato, V.; Capurso, A.; et al. Circulating biomarkers of cognitive decline and dementia. Clin. Chim. Acta 2006, 364, 91–112. [CrossRef] [PubMed]
4. Beal, M.F. Oxidative damage as an early marker of Alzheimer’s disease and mild cognitive impairment. Neurobiol. Aging 2005, 26, 585–586. [CrossRef] [PubMed]
5. Butterfield, D.A.; Reed, T.; Perluigi, M.; de Marco, C.; Coccia, R.; Cini, C.; Sultana, R. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neurosci. Lett. 2006, 397, 170–173. [CrossRef] [PubMed]
6. Butterfield, D.A.; Reed, T.; Perluigi, M.; de Marco, C.; Coccia, R.; Keller, J.N.; Markesbery, W.R.; Sultana, R. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: Implications for the role of nitration in the progression of Alzheimer’s disease. Brain Res. 2007, 1148, 243–248. [CrossRef] [PubMed]
7. Mangialasche, F.; Polidori, M.; Monastero, R.; Ercolani, S.; Camarda, C.; Cecchetti, R.; Mecocci, P. Biomarkers of oxidative and nitrosative damage in Alzheimer’s disease and mild cognitive impairment. Ageing Res. Rev. 2009, 8, 285–305. [CrossRef] [PubMed]
8. Fernandes, M.A.; Santana, I.; Januario, C.; Cunha, L.; Oliveira, C.R. Decreased superoxide dismutase in erythrocytes from patients with Alzheimer’s disease. Med. Sci. Res. 1993, 21, 679–682.
9. Baldeiras, I.; Santana, I.; Proença, M.T.; Garrucho, M.H.; Pascoal, R.; Rodrigues, A.; Duro, D.; Oliveira, C.R. Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer’s disease. J. Alzheimer’s Dis. 2008, 15, 117–128.
10. Greilberger, J.; Koidl, C.; Greilberger, M.; Lamprecht, M.; Schroecksnadel, K.; Leblhuber, F.; Fuchs, D.; Oettl, K. Malondialdehyde, carbonyl proteins and albumindisulphide as useful oxidative markers in mild cognitive impairment and Alzheimer’s disease. Free Radic. Res. 2008, 42, 633–638. [CrossRef] [PubMed]
11. Lovell, M.A.; Markesbery, W.R. Oxidative damage in mild cognitive impairment and early Alzheimer’s disease. J. Neurosci. Res. 2007, 85, 3036–3040. [CrossRef] [PubMed]
12. Cosentino, S.; Scarmeas, N.; Helzner, E.; Glymour, M.M.; Brandt, J.; Albert, M.; Blacker, D.; Stern, Y. APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology 2008, 70, 1842–1849. [CrossRef] [PubMed]
13. Anstey, K.; Christensen, H. Education, activity, health, blood pressure, and apolipoprotein E as predictors of cognitive change in old age: A review. Gerontology 2000, 46, 163–177. [CrossRef] [PubMed]
14. Jofre-Monseny, L.; Minihane, A.M.; Rimbach, G. Impact of apoE genotype onoxidative stress, inflammation and disease risk. Mol. Nutr. Food Res. 2008, 52, 131–145. [CrossRef] [PubMed]
15. Zhang, H.; Wu, L.M.; Wu, J. Cross-talk between apolipoprotein E and cytokines. Mediators Inflamm. 2011, 94, 90–72. [CrossRef] [PubMed]
16. Miyata, M.; Smith, J.D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat. Genet. 1996, 14, 55–61. [CrossRef] [PubMed]
17. Hayes, J.D.; Strange, R.C. Glutathione S-transferase polymorphism and their biological consequences. Pharmacology 2000, 61, 154–166. [CrossRef] [PubMed]
18. Lovell, M.A.; Xie, C.; Markesbery, W.R. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer’s disease. Neurology 1998, 51, 1562–1566. [CrossRef] [PubMed]
19. Pemble, S.; Schroeder, K.R.; Spencer, S.R.; Meyer, D.J.; Hallier, E.; Bolt, H.M.; Ketterer, B.; Taylor, J.B. Human glutathione S-transferase (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J. 1994, 300, 271–276. [CrossRef] [PubMed]
20. Seidegard, J.; Vorachek, W.R.; Pero, R.W.; Pearson, W.R. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc. Natl. Acad. Sci. USA 1988, 85, 7293–7297. [CrossRef] [PubMed]
21. Chen, B.; Cao, L.; Zhou, Y.; Yang, P.; Wan, H.W.; Jia, G.Q.; Liu, L.; Wu, X.T. Glutathione S-transferase T1 (GSTT1) gene polymorphism and gastric cancer susceptibility: A meta-analysis of epidemiologic studies. Dig. Dis. Sci. 2010, 55, 1831–1838. [CrossRef] [PubMed]
22. Nasreddine, Z.S.; Phillips, N.A.; Bédirian, V.; Charbonneau, S.; Whitehead, V.; Collin, I.; Cummings, J.L.; Chertkow, H. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 2005, 53, 695–699. [CrossRef] [PubMed]
23. Mitchell, A.J.; Malladi, S. Screening and case finding tools for the detection of dementia. Part I: evidence-based meta-analysis of multidomain tests. Am. J. Geriatr. Psychiatry 2010, 18, 759–782. [CrossRef] [PubMed]
24. Zhong, S.; Wyllie, A.H.; Barnes, D.; Wolf, C.R.; Spurr, N.K. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 1993, 14, 1821–1824. [CrossRef] [PubMed]
25. Zhong, S.L.; Zhou, S.; Chen, X.; Huang, M. Rapid determination of common mutation in glutathione S-transferase gene by PCR-based methods in healthy Chinese. Clin. Chim. Acta 2006, 364, 205–208. [CrossRef] [PubMed]
26. Hixson, J.E.; Vernier, D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid. Res. 1990, 31, 545–548. [PubMed]
27. Nierenberg, D.W.; Nann, S.L. A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples. Am. J. Clin. Nutr. 1992, 56, 417–426. [PubMed]
28. Friedewald, W.T.; Levy, R.I.; Fredrickson, D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18, 499–502. [PubMed]
29. Dergunov, A.D. Apolipoprotein E genotype as a most significant predictor of lipid response at lipid-lowering therapy: Mechanistic and clinical studies. Biomed. Pharmacother. 2011, 65, 597–603. [CrossRef] [PubMed]
30. Heeren, J.; Beisiegel, U.; Grewal, T. Apolipoprotein E recycling: Implications for dyslipidemia and atherosclerosis. Arterioscler Thromb. Vasc. Biol. 2006, 26, 442–448. [CrossRef] [PubMed]
31. Davignon, J.; Gregg, R.E.; Sing, C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988, 8, 1–21. [CrossRef] [PubMed]
32. Liu, H.W.; Zhang, F.; Fan, P.; Bai, H.; Zhang, J.X.; Wang, Y. Effects of apolipoprotein E genotypes on metabolic profile and oxidative stress in southwest Chinese women with polycystic ovary syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013, 170, 146–151. [CrossRef] [PubMed]
33. Tejedor, M.T.; Garcia-Sobreviela, M.P.; Ledesma, M.; Arbones-Mainar, J.M. The apolipoprotein E polymorphism rs7412 associates with body fatness independently of plasma lipids in middle aged men. PLoS ONE 2014, 9, e108605. [CrossRef] [PubMed]
34. Tao, Q.Q.; Chen, Y.; Liu, Z.J.; Sun, Y.M.; Yang, P.; Lu, S.J.; Xu, M.; Dong, Q.Y.; Yang, J.J.; Wu, Z.Y. Associations between apolipoprotein E genotypes and serum levels of glucose, cholesterol, and triglycerides in a cognitively normal aging Han Chinese population. Clin. Interv. Aging 2014, 9, 1063–1067. [PubMed]
35. Shahar, S.; Lee, L.K.; Rajab, N.; Lim, C.L.; Harun, N.A.; Noh, M.F.; Mian-Then, S.; Jamal, R. Association between vitamin A, vitamin E and apolipoprotein E status with mild cognitive impairment among elderly people in low-cost residential areas. Nutr. Neurosci. 2013, 16, 6–12. [CrossRef] [PubMed]
36. Quintino-Santos, S.; Diniz, B.S.; Firmo, J.O.; Moriguchi, E.H.; Lima-Costa, M.F.; Castro-Costa, E. APOE #4 allele is associated with worse performance in memory dimensions of the mini-mental state examination: The Bambuí Cohort Study of Aging. Int. J. Geriatr. Psychiatry 2015, 30, 573–579. [CrossRef] [PubMed]
37. De Blasi, S.; Montesanto, A.; Martino, C.; Dato, S.; de Rango, F.; Bruni, A.C.; Mari, V.; Feraco, E.; Passarino, G. APOE polymorphism affects episodic memory among non-demented elderly subjects. Exp. Gerontol. 2009, 44, 224–227. [CrossRef] [PubMed]
38. Bernardini, S.; Bellincampi, L.; Ballerini, S.; Federici, G.; Iori, R.; Trequattrini, A.; Ciappi, F.; Baldinetti, F.; Bossù, P.; Caltagirone, C.; et al. Glutathione S-transferase P1*C allelic variant increases susceptibility for late-onset Alzheimer disease: Association study and relationship with apolipoprotein E epsilon4 allele. Clin. Chem. 2005, 51, 944–951. [CrossRef] [PubMed]
39. Spalletta, G.; Bernardini, S.; Bellincampi, L.; Federici, G.; Trequattrini, A.; Ciappi, F.; Bria, P.; Caltagirone, C.; Bossù, P. Glutathione S-transferase P1 and T1 gene polymorphisms predict longitudinal course and age at onset of Alzheimer disease. Am. J. Geriatr. Psychiatry 2007, 15, 879–887. [CrossRef] [PubMed]
40. Corder, E.H.; Saunders, A.M.; Strittmatter, W.J.; Schmechel, D.E.; Gaskell, P.C.; Small, G.W.; Roses, A.D.; Haines, J.L.; Pericak-Vance, M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in the late onset families. Science 1993, 261, 921–923. [CrossRef] [PubMed]
41. Abdollahi, M.R.; Guthrie, P.A.; Smith, G.D.; Lawlor, D.A.; Ebrahim, S.; Day, I.N. Integrated single-label liquid-phase assay of APOE codons 112 and 158 and a lipoprotein study in British women. Clin. Chem. 2006, 52, 1420–1423. [CrossRef] [PubMed]
42. Talmud, P.J.; Stephens, J.W.; Hawe, E.; Demissie, S.; Cupples, L.A.; Hurel, S.J.; Humphries, S.E.; Ordovas, J.M. The significant increase in cardiovascular disease risk in APOEepsilon4 carriers is evident only in men who smoke: Potential relationship between reduced antioxidant status and ApoE4. Ann. Hum. Genet. 2005, 69, 613–622. [CrossRef] [PubMed]
43. Boer, J.M.; Feskens, E.J.; Schouten, E.G.; Havekes, L.M.; Seidell, J.C.; Kromhout, D. Lipid profiles reflecting high and low risk for coronary heart disease: Contribution of apolipoprotein E polymorphism and lifestyle. Atherosclerosis 1998, 136, 395–402. [CrossRef]
44. Piacentini, S.; Polimanti, R.; Porreca, F.; Martínez-Labarga, C.; de Stefano, G.F.; Fuciarelli, M. GSTT1 and GSTM1 gene polymorphisms in European and African populations. Mol. Biol. Rep. 2011, 38, 1225–1230. [CrossRef] [PubMed]
45. Emanuele, E.; Peros, E.; Tomaino, C.; Feudatari, E.; Bernardi, L.; Binetti, G.; Maletta, R.; D’Angelo, A.; Montagna, L.; Bruni, A.C et al. Apolipoprotein (a) null phenotype is related to a delayed age at onset of Alzheimer’s disease. Neurosci. Lett. 2004, 357, 45–48. [CrossRef] [PubMed]
46. Fischer, K.; da Costa, L.A.; García-Bailo, B.; Borchers, C.H.; El-Sohemy, A. Glutathione S-transferase (GST) M1, but not GSTT1, genotype influences plasma proteomic profiles in Caucasian and East Asian young adults. J. Proteome. Res. 2012, 11, 5022–5033. [CrossRef] [PubMed]
47. Song, H.; Saito, K.; Seishima, M.; Noma, A.; Urakami, K.; Nakashima, K. Cerebrospinal fluid apo E and apo AI concentrations in early- and lateonset Alzheimer’s disease. Neurosci. Lett. 1997, 231, 175–178. [CrossRef]